CT1812

Ascending Dose Study of CT1812 in Healthy Volunteers

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Drug Interaction Study of CT1812 in Healthy Volunteers

Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease